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Abstract
Rationale: Patients with idiopathic bronchiectasis are
predominantly female and have an asthenic body morphotype
and frequent nontuberculous mycobacterial respiratory infections.
They also demonstrate phenotypic features (scoliosis, pectus
deformity, mitral valve prolapse) that are commonly seen in
individuals with heritable connective tissue disorders.
Objectives: To determine whether lumbar dural sac size is
increased in patients with idiopathic bronchiectasis as compared
with control subjects, and to assesswhether dural sac size is correlated
with phenotypic characteristics seen in individuals with heritable
connective tissue disorders.
Methods: Two readers blinded to diagnosis measured anterior–
posterior and transverse dural sac diameter using L1–L5 magnetic
resonance images of 71 patients with idiopathic bronchiectasis, 72
control subjects without lung disease, 29 patients with cystic fibrosis,
and 24 patients with Marfan syndrome. We compared groups by
pairwise analysis of means, using Tukey’s method to adjust for
multiple comparisons. Dural sac diameter association with
phenotypic and clinical features was also tested.
Measurements and Main Results: The L1–L5 (average)
anterior–posterior dural sac diameter of the idiopathic
bronchiectasis group was larger than those of the control group
(P, 0.001) and the cystic fibrosis group (P = 0.002). There was a
strong correlation between increased dural sac size and the
presence of pulmonary nontuberculous mycobacterial infection
(P = 0.007) and long fingers (P = 0.003). A trend toward larger
dural sac diameter was seen in those with scoliosis (P = 0.130)
and those with a family history of idiopathic bronchiectasis
(P = 0.149).
Conclusions: Individuals with idiopathic bronchiectasis
have an enlarged dural sac diameter, which is associated with
pulmonary nontuberculous mycobacterial infection, long
fingers, and family history of idiopathic bronchiectasis. These
findings support our hypothesis that “idiopathic” bronchiectasis
development reflects complex genetic variation in heritable
connective tissue and associated transforming growth factor-
b–related pathway genes.
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Idiopathic bronchiectasis, or bronchiectasis
without a known cause, affects more than
100,000 Americans and carries substantial
morbidity and mortality. Impaired mucus
clearance results in recurrent infections,
persistent inflammation, and dilation of the
airways, reflecting loss of integrity of the
supportive connective tissue network of
the airways.
The authors of prior publications
have reported that idiopathic bronchiectasis
has a female predilection and a high
prevalence of an asthenic body morphotype,
as well as an association with pulmonary
nontuberculous mycobacterial infection.
In addition, other phenotypic abnormalities
occur at a higher frequency in these
individuals than in the general population,
including pectus deformity, scoliosis,
mitral valve prolapse, high-arched palate,
arachnodactyly, and hypermobility (1–5).
These skeletal and cardiovascular
manifestations are similar to phenotypic
features noted in individuals with
heritable connective tissue disorders such
as Marfan syndrome, Loeys-Dietz
syndrome, and Ehlers-Danlos syndrome.
Patients with these disorders
demonstrate diverse manifestations of
disorganized connective tissue matrices,
particularly in the cardiovascular and
skeletal systems, but also in the lung (6–9).
Autosomal dominant mutations result in
excessive transforming growth factor
(TGF)-b activation and signaling, which
are important factors in the connective
tissue abnormalities seen in individuals
with these syndromes.
Phenotypic manifestations in Marfan
syndrome include 25–60% with scoliosis
or kyphoscoliosis (10); more than 65% with
pectus abnormalities, including excavatum
and carinatum (10, 11); 85% with joint
hypermobility (11); 91% with mitral valve
prolapse (12); and 60% with aortic root
dilation (12). High-arched palate and long
fingers (arachnodactyly) are also frequent
findings in Marfan syndrome (11).
Manifestations in Loeys-Dietz syndrome
are similar: 70% with scoliosis (13), 51%
with pectus deformity (13), more than
20% with mitral valve prolapse (14), 87%
with aortic root dilation (13), and at least
half with joint hypermobility and long
fingers (13). High-arched palate is also seen
(15). In individuals with Ehlers-Danlos
syndrome, the prevalence of these clinical
features is more varied because of
subclassifications within this diagnosis.
Joint hypermobility is the hallmark
characteristic of all Ehlers-Danlos syndrome
subtypes (16). Aortic root dilation is seen
in 10–28% (17, 18), and mitral valve
prolapse is seen in 6–66% (17, 18). High-
arched palate, scoliosis, and pectus
abnormalities may also be seen (19).
Individuals with Marfan syndrome and
other patients with heritable connective
tissue disorders have lung disease, with
an increased frequency of pneumonia and
bronchiectasis (19–23) as well as apical
blebs and spontaneous pneumothorax; the
latter is included in the systemic score of
the modified Ghent criteria for Marfan
syndrome (24). Dural ectasia, or dilation of
the dural sac surrounding the spinal cord, is
present in Marfan syndrome (25), Loeys-
Dietz syndrome (26–28), and variant
Ehlers-Danlos syndromes (29–31). It does
not occur in the general population in the
absence of neurofibromatosis type 1, severe
scoliosis, trauma, or tumors (32). The
prevalence of dural ectasia in the Marfan
syndrome population is estimated to be
between 63 and 90% (10, 25), and its
prevalence in patients with Loeys-Dietz
syndrome is estimated to be between 50
and 73% (26–28). Only case reports of
dural ectasia occurring in Ehlers-Danlos
syndrome and other heritable connective
tissue disorders have been published.
Dural sac size can easily be measured
using sagittal images of the lumbar spine
obtained by magnetic resonance (MR)
imaging or computed tomography (CT)
(32–34). Measurements obtained in this
way can be reproduced by readers with
different experience using a standardized
and validated method, and they are not
influenced by age, sex, height, or race (34).
Following the observation of an
apparent increase in dural sac size in a few
individuals with idiopathic bronchiectasis,
and in light of the overlap of heritable
connective tissue disorder features in
individuals with idiopathic bronchiectasis
and the increasingly recognized presence of
bronchiectasis in heritable connective tissue
disorders, we sought to examine lumbar MR
images of individuals with idiopathic
bronchiectasis to determine if there was also
a significant increase in dural sac size as
compared with control individuals. If true,
this would be congruent with the concept
that genetic variation in heritable connective
tissue disorder genes and TGF-b–related
pathways contributes to the risk of
bronchiectasis development.
Our secondary aim was to determine if
increased dural sac size in subjects with
bronchiectasis was associated with physical
characteristics that overlap with heritable
connective tissue disorders, which would
further support our hypothesis that
bronchiectasis is a complex genetic disorder
reflecting genetic variation in connective
tissue disorder genes and TGF-b–related
pathways. Some of the results of these
studies have been reported previously in the
form of an abstract (35).
Methods
The local institutional review board
approved the present study. Informed
consent and MR imaging safety screening
forms were completed in prospectively
studied subjects, but informed consent was
waived for evaluation of preexisting MR and
CT images. All data were recorded in a
Health Insurance Portability and
Accountability Act–compliant, protected
database.
Study Subjects
Measurements were obtained from four
groups of adults (>18 yr of age). Subjects
with idiopathic bronchiectasis (n = 71
subjects from 66 families) included
individuals with bronchiectasis in two or
more lobes; less than a 10–pack-year
smoking history; and exclusion of other
potential etiologies, including cystic
fibrosis, primary ciliary dyskinesia, alpha-1
antitrypsin deficiency, allergic
bronchopulmonary aspergillosis,
inflammatory bowel disease, autoimmune
disease, immune deficiency, prior solid
organ transplant, and prior history of
tuberculosis. None of the subjects with
bronchiectasis met the clinical criteria
required for a diagnosis of a heritable
connective tissue disorder.
Control subjects (n = 72) without lung
or spinal disease or evidence of heritable
connective tissue disorders were imaged as
previously described (34). Subjects with
cystic fibrosis (n = 29) were confirmed to
carry two disease-causing mutations in
CFTR and served to control for the
possibility that coughing might cause
increased intracranial and intrathecal
pressure and thereby affect dural size.
An additional 24 subjects carried a
genetic or clinical diagnosis of Marfan
syndrome and had preexisting MR imaging
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or CT examinations of the lumbosacral
spine available for measurement (34).
Exclusion criteria for all subjects included
severe thoracic or lumbar scoliosis (Cobb
angle, >30 degrees), thoracic or lumbar
spinal surgery, spinal stenosis, or spinal
injury.
Imaging Protocol and Analysis
Both preexisting and prospective lumbar
MR imaging examinations were performed
as described by Daniels and colleagues (34).
Additional details are provided in the
online supplement.
Determination of Phenotypic Features
Pectus abnormalities were classified as
pectus excavatum or pectus carinatum using
a corrected Haller index (36) or if there
was a sternal tilt resulting in chest wall
asymmetry that was noted in a physical
examination or by chest imaging. Scoliosis
was defined as the presence of a single
spinal curve with a Cobb angle of 8 degrees
or more or as the presence of two spinal
curves, each having a Cobb angle of at least
5 degrees as measured on a posterior–
anterior chest radiograph using the Cobb
method (37).
Mitral valve prolapse was defined by
findings of redundant mitral valve leaflets
with prolapse into the left ventricle noted
on an echocardiogram, but the presence
of mitral regurgitation was not required.
Fingers disproportionately long as
compared with the palm of the hand
were assessed by the (Walker) wrist sign
and the (Steinberg) thumb sign (24, 38).
A high-arched palate was present when the
maximum palate height was greater than
twice the height of the teeth (39). Joint
hypermobility was determined by applying
the Brighton criteria (40). This includes the
Beighton score (40), which requires
quantified assessment of hyperextension
using a goniometer. If joint hypermobility
could not be assessed in person, a validated
5-point questionnaire for generalized joint
hypermobility (41) was completed by
phone or by e-mail.
Methods Used to Determine
Clinical Features
Lung function was measured using
prebronchodilator spirometric
measurements obtained according to
American Thoracic Society guidelines (42).
Percent predicted values were calculated
using published reference values (43). The
presence of bronchiectasis was determined
for each lobe of the lung; the lingula
was considered as the sixth lobe (separate
from the left upper lobe). Severity of
bronchiectasis was classified as mild,
moderate, or severe as defined in Table E1
in the online supplement. The methods
we used for defining infection status and
family history of bronchiectasis are
provided in detail in the online supplement.
Statistical Analysis
Linear regression was performed to
compare the effects of covariates, including
height, sex, and race, on anterior–posterior
dural sac diameter (AP-DSD) and
transverse dural sac diameter (TR-DSD)
measurements of L1 through L5 and
the L1–L5 average. For the effect of the
covariate of age, we regressed on the
oldest patient per family (n = 66). Pearson’s
correlation was used to calculate the
unadjusted correlation between readers
1 and 2 for the AP-DSD and TR-DSD
measurements. Measurements for AP-DSD
and TR-DSD by reader 1 were compared
between all four groups using pairwise
comparison of means. Tukey’s method was
used to adjust for multiple comparisons.
Within the idiopathic bronchiectasis
group, comparison of L1–L5 (average)
AP-DSD by individual dichotomous
clinical characteristic variables was
performed using Student’s t test. For
comparison of men and women within
the idiopathic bronchiectasis group,
Student’s t test was used for continuous
variables, including FEV1, body mass
index (BMI), age, and height. Chi-square
and Fisher’s exact tests were used for
comparison of categorical variables such as
Pseudomonas and mycobacterial positivity,
radiographic findings consistent with
nontuberculous mycobacterial disease, and
family member with bronchiectasis. The
Wilcoxon-Mann-Whitney test was used for
comparison of lobes with bronchiectasis.
For all tests, P, 0.05 indicated a
statistically significant difference. All
statistical analysis was performed using
STATA release 2013 software (StataCorp,
College Station, TX).
Results
Demographics
Demographic features of the IB study
subjects are summarized in Table 1. The
bronchiectasis group was older (mean age,
57 yr) and predominantly female (75%).
As expected, men were taller than women,
but there was no significant difference by
sex for age (P = 0.99), BMI (P = 0.23),
prevalence of Pseudomonas aeruginosa
or mycobacterial infection (P = 0.62
and P = 0.22, respectively), lobes with
bronchiectasis (P = 0.44), or FEV1 percent
predicted (P = 0.7).
The average FEV1 was consistent with
mild airway obstruction, but the broad
range of FEV1 reflects the diversity of
disease severity. Overall, the mean number
of lobes affected was 4.7, with the lingula
and the right middle lobe being the most
severely affected (Table E2). Nearly half of
subjects had P. aeruginosa cultured from
respiratory samples (46%), and over one-
third had environmental mycobacterial
respiratory disease (37.5%).
Strikingly, of the 66 families included in
the sample, 21% had more than one
individual in the family diagnosed with
idiopathic bronchiectasis, and this tended to
be more common in women (P = 0.051).
Scoliosis and pectus abnormalities were
present more often in the subjects with
bronchiectasis than in the control group
and compared with population estimates
(5) (Table E3). Pectus abnormalities were
present in women significantly more often
than in men (P = 0.005).
Subjects with bronchiectasis with a
prior echocardiogram had mitral valve
prolapse detected much more frequently
than in the general population (44).
Hypermobility also was more prevalent
in the bronchiectasis group as compared
with population estimates (45). While a
positive wrist sign and high-arched palate
were seen more often in the bronchiectasis
group than in the general population, the
thumb sign reflected population estimates
(38). Positive wrist sign tended to be
present more often in the women with
bronchiectasis subgroup than in men with
bronchiectasis (P = 0.091).
Dural Sac Dimensions
We examined dural sac size in patients with
idiopathic bronchiectasis and compared
measurements with those in the control,
Marfan syndrome, and cystic fibrosis groups
(Table E4). The subjects in the idiopathic
bronchiectasis group tended to be older
than those in the other groups and had a
significantly lower BMI than those in the
control group (P, 0.001). Whereas the
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height of the subjects with idiopathic
bronchiectasis (by sex) was similar to that
of control subjects, these subjects were
shorter than those with Marfan syndrome
(P, 0.001) and taller than those with cystic
fibrosis (P = 0.05).
Overall, there was good correlation
between the two readers for all groups
regarding AP-DSD and TR-DSD (Table E5).
Similarly to our prior publication (34), we
found greater within-group variability for
TR-DSD measurements than for AP-DSD
measurements. We focused our present
analysis on AP-DSD measurements, based
on our prior study data demonstrating a
better area under the curve for the
receiver operating characteristics (34).
Mirroring observations from our prior
study (34), L1–L5 (average) AP-DSD
measurements for the idiopathic
bronchiectasis group and the cystic
fibrosis group did not significantly differ
by age, sex, height, or race.
The L1–L5 (average) AP-DSD of the
idiopathic bronchiectasis group (1.526
0.18 cm) (Figure 1) was significantly larger
than those in the control group (1.386
0.15 cm; P, 0.001) and the cystic fibrosis
group (1.396 0.15 cm; P = 0.002), and
the dural sac diameter at each individual
vertebral level in the idiopathic
bronchiectasis group was also significantly
larger (Table E6). The Marfan syndrome
group tended to have a significantly larger
dural sac size than that in the idiopathic
bronchiectasis group (1.616 0.17 cm;
P = 0.084). There was no significant
difference between the Marfan syndrome
and idiopathic bronchiectasis groups at
individual vertebral levels from L1 to L3;
however, at the lower vertebral levels
(L4 and L5), the Marfan syndrome group
had significantly larger AP-DSD
measurements.
We saw similar results for L1–L5
(average) TR-DSD measurements (Figure 2).
The measurement in the idiopathic
bronchiectasis group (2.026 0.24 cm) was
significantly larger than those in the control
(1.896 0.17 cm) and cystic fibrosis groups
(1.786 0.19 cm) (P, 0.001). The L1–L5
(average) TR-DSD of the Marfan syndrome
group (2.226 0.32 cm) was larger than that
in the L1–L5 (average) TR-DSD of the
idiopathic bronchiectasis group (P = 0.001).
Sagittal and axial MR images of the dural sac
in a representative patient with idiopathic
bronchiectasis are compared in Figure 3
with images obtained from a healthy control
subject and a patient with Marfan syndrome.
We saw a robust correlation between
increased dural sac diameter and presence of
nontuberculous mycobacteria (Figure 4A).
Individuals with at least two mycobacterial
cultures positive for the same organism had
significantly larger L1–L5 (average)
AP-DSD than those without pulmonary
mycobacterial infection (P = 0.007)
(Figure 4A). A positive wrist sign
(connoting longer fingers) was also
significantly associated with larger L1–L5
(average) AP-DSD measurements
(P = 0.003) (Figure 4B). Because only four
subjects had a positive thumb sign, no
conclusion could be drawn on that basis.
Individuals with nonsevere scoliosis
(and therefore not excluded from our study)
tended to have larger L1–L5 (average)
AP-DSD measurements than those without
scoliosis (P = 0.130) (Figure 4C). There was
at least one additional family member with
bronchiectasis in 14 (21%) of the 66
families. A family history of bronchiectasis
tended to be associated with increased dural
sac diameter but did not reach statistical
significance (P = 0.149) (Figure 4D). No
difference was observed in L1–L5 (average)
AP-DSD based on presence of sternal
Table 1. Demographics of subjects with idiopathic bronchiectasis
Female (n = 53) Male (n = 18) P Value
Age, yr, mean (range) 57.3 (18–89) 57.3 (19–81) P = 1
BMI, mean (range) 23.2 (12.9–47.8) 24.9 (16.3–34.3) P = 0.23
Height, cm, mean (range) 162.7 (149.5–175.5) 177.0 (156.6–187.6) P, 0.001
FEV1, % predicted, mean (range) 74 (19–111) 72 (29–119) P = 0.70
Pseudomonas aeruginosa, % (individuals positive/individuals
tested)
48% (25/52) 41% (7/17) P = 0.62
NTM, % (individuals positive/individuals tested) 42% (21/50) 21% (3/14) P = 0.22
Lobes with bronchiectasis including lingula, mean (median) 4.79 (6) 4.56 (4) P = 0.44
Definition of abbreviations: BMI = body mass index; NTM = nontuberculous Mycobacterium.
Control (N = 72) IB (N = 71) Marfan (N = 24) CF (N = 29)
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Figure 1. Comparison of L1–L5 (average) anterior–posterior dural sac diameter (AP-DSD) by
diagnosis. The L1–L5 (average) AP-DSD of the idiopathic bronchiectasis (IB) group is significantly
larger than those in the control group (P, 0.001) and the cystic fibrosis (CF) group (P = 0.002). The
Marfan syndrome group is trending toward having a significantly larger dural sac size than the IB
group (P = 0.094).
ORIGINAL RESEARCH
Daniels, Birchard, Lowe, et al.: Dural Sac Dilation in Idiopathic Bronchiectasis 1715
abnormalities (P = 0.524), high-arched
palate (P = 0.354), hypermobility (as
defined by Brighton score) (P = 0.749),
or respiratory P. aeruginosa infection
(P = 0.45).
As a way to look at the relationship
between dural sac diameter and lung
disease, we compared L1–L5 (average)
AP-DSD with spirometric parameters and
severity of bronchiectasis (Table E1). In
that comparison, we observed no
relationship for FEV1 percent predicted
(P = 0.904), FEV1/FVC ratio (P = 0.474), or
FEF25–75% predicted (P = 0.971). Although
we found no relationship between dural
sac size and whole-lung bronchiectasis
severity score (P = 0.30), there was a modest
association between increased dural sac
diameter and a combined right middle
lobe and lingular bronchiectasis score
(P = 0.049).
Discussion
Bronchiectasis develops in the setting of
impaired mucus clearance, which results
in recurrent infections, persistent
inflammation, and dilation of the airways,
reflecting loss of integrity of the supportive
connective tissue network of the airways.
Although pathophysiological mechanisms
for genetic recessive forms of bronchiectasis
(cystic fibrosis and primary ciliary
dyskinesia) reflect defective mucociliary
and cough clearance, the mechanisms
involved in idiopathic bronchiectasis
are unknown.
The phenotypic features seen in
idiopathic bronchiectasis, including a high
prevalence of an asthenic body morphotype,
pectus deformity, scoliosis, mitral valve
prolapse, and hypermobility, are also
common in patients with heritable
connective tissue disorders, such as Marfan
syndrome, Ehlers-Danlos syndrome, and
Loeys-Dietz syndrome. Moreover, patients
with heritable connective tissue
disorders have disorganized connective
tissue matrices within the lungs that
manifest as spontaneous pneumothorax,
pneumonia, and bronchiectasis. Autosomal
dominant mutations result in abnormal
fibrillins in Marfan syndrome and
congenital contractural arachnodactyly
(Beals syndrome) and in defects in the
TGF-b receptor in Loeys-Dietz syndrome
and vascular Ehlers-Danlos syndrome.
These lead to excessive TGF-b activation
and signaling, which play a key
pathophysiologic role in the connective
tissue abnormalities in these syndromes
(6, 7, 46–48), including dilation of the dural
sac (dural ectasia), implying reduced
integrity of this connective tissue matrix
(25, 28, 47).
The morphotypic features seen in
idiopathic bronchiectasis (asthenic body
morphotype, pectus deformities) overlap
with heritable connective tissue disorders,
suggesting that genetic variants in the
TGF-b1 pathway and signaling cascade
may be associated with bronchiectasis in a
subset of patients. This observation
prompted us to rigorously assess dural sac
size in a large cohort of patients with
idiopathic bronchiectasis (n = 71) using
lumbosacral MR imaging.
In this large cohort of patients with
idiopathic bronchiectasis, we saw an
increased prevalence of multiple phenotypes
that are typically reported in these
patients, such as scoliosis, pectus, and
mitral valve prolapse (Table E6). In
addition, we report novel findings of
enlarged dural sac size in patients with
idiopathic bronchiectasis compared with
control subjects without lung disease
(P, 0.001) and with those with cystic
fibrosis who had bronchiectasis reflecting
mutations in CFTR (P, 0.002). Indeed,
dural sac enlargement in idiopathic
bronchiectasis approached that seen in
Marfan syndrome measured as both
AP-DSD and TR-DSD (P = 0.094 and
P = 0.001, respectively). These findings
support our hypothesis that the
development of “idiopathic” bronchiectasis
in many people reflects, at least in part,
complex genetic variation in connective
tissue disorder genes and associated
TGF-b–related pathogenic pathway genes.
This concept was reinforced by the
presence of some phenotypic features in
patients with idiopathic bronchiectasis
that were associated with increased dural
sac size, including long fingers as assessed
by the wrist sign (P = 0.003) and scoliosis
(P = 0.130). It should be noted that the
association of dural sac diameter with
scoliosis would likely have been stronger if
we had not had to exclude subjects with
severe scoliosis in our quantitation of dural
sac size. Strikingly, we discovered in our
patients with idiopathic bronchiectasis that
respiratory infection with environmental
mycobacteria was strongly associated with
dural sac size (P = 0.007). It is noteworthy
that the subjects with mycobacteria
were largely women (21 of 24) and that
subjects with mycobacteria were 8.7 years
older than those without (62.6 vs. 53.9 yr).
Although this older age in subjects with
mycobacteria would provide the opportunity
for its environmental acquisition, logistic
regression including age and nontuberculous
mycobacterial status as interaction terms
showed that older age alone did not fully
explain the association of mycobacteria
with larger dural sac size (P = 0.23).
In a recent study of genetic variation
in patients with respiratory infection
with nontuberculous mycobacteria and
bronchiectasis, along with some family
members without these organisms,
Control (N = 72) IB (N = 71) Marfan (N = 24) CF (N = 29)
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Figure 2. Comparison of L1–L5 (average) transverse dural sac diameter (TR-DSD) by diagnosis. The
diameter in the idiopathic bronchiectasis (IB) group is significantly larger than those in the control
group (P, 0.001) and the cystic fibrosis (CF) group (P, 0.001), but it is significantly smaller than that
in the Marfan syndrome group (P = 0.001).
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researchers reported results that are
congruent with our hypothesis that genetic
variants in heritable connective tissue
disorders contribute to the development
of bronchiectasis (49). Specifically, these
87 individuals (with and without
mycobacteria) were exome sequenced,
and data were filtered to include only
genetic variants that had a population
frequency less than 2% and the ability to
affect protein structure. Within the 24
“connective tissue” genes surveyed, 99
pulmonary nontuberculous mycobacteria–
associated variants passed the filters.
As compared with the 1000 Genomes
Project, family members with and without
nontuberculous mycobacteria infection
were found to have more low-frequency,
protein-affecting variants in these genes,
of which 21 would be considered “heritable
connective tissue disorder” genes or in
TGF-b–related pathways.
These findings of an increased burden
of genetic variants in the heritable
connective tissue disorder genes in patients
with bronchiectasis and nontuberculous
mycobacterial infection, as well as in family
members without infection (but 78% of
whom had bronchiectasis, scoliosis, pectus
excavatum, or joint hypermobility), are
congruent with our findings of increased
dural sac diameter in patients with
idiopathic bronchiectasis with associated
phenotypes (including long fingers, aortic
root diameter, and scoliosis) and the
presence of pulmonary mycobacterial
infection. A similar overlap of the features of
heritable connective tissue disorders among
family members of patients with
mycobacteria was reported in an earlier
publication (5). Therefore, it is not
surprising that we found a trend toward
increased prevalence of bronchiectasis
among family members of patients with
idiopathic bronchiectasis, as they are likely
to share similar genetic variants in heritable
connective tissue disorder genes. The lack
of statistical significance is likely due to
limited medical history and diagnostic
imaging availability for earlier generations
in an older patient population.
Limitations
Our present study has several limitations
that should be recognized. As expected
on the basis of prior publications, our
population of patients with idiopathic
bronchiectasis included a relatively
small number of men with idiopathic
bronchiectasis, and the preponderance
of women with idiopathic bronchiectasis
largely drove our results. Therefore,
our findings may not fully reflect these
associations inmen with bronchiectasis. The
prevalence of mitral valve prolapse in the
idiopathic bronchiectasis group could be
overestimated because we used the number
of echocardiograms, rather than the total
number of individuals, as the denominator.
Another limitation is that we lacked
hypermobility data and somemorphometric
data (e.g., wrist and thumb sign, mitral valve
Figure 3. Sagittal (A–C ) and axial (D–F) T2-weighted three-dimensional turbo spin-echo magnetic resonance images of the lumbosacral spine. Axial
images are at the L2 vertebral level. Measurement locations of anterior–posterior dural sac diameter (AP-DSD) (orange lines) and transverse dural
sac diameter (TR-DSD) (blue lines) of a healthy control subject (A, D), of a subject with idiopathic bronchiectasis (B, E ), and of a patient with Marfan
syndrome (C, F).
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prolapse) for control subjects. We compared
the prevalence of these findings with
population estimates when possible, but the
prevalence of these findings in our control
population might differ from published
population estimates.
Implications
In the future, we will extend assessment
of the dural sac by lumbar MR imaging to
chest CT of the lower thoracic and upper
lumbar spine to determine if dural sac
enlargement in patients with idiopathic
bronchiectasis can be detected by chest CT
and whether they correlate with lumbar
dural sac measurements by MR imaging.
If true, then all patients with idiopathic
bronchiectasis can be characterized for dural
sac size using already available chest CT
scans. This “biomarker” might also identify
individuals who present with recurrent
airway infections who are at risk for
developing progressive bronchiectasis as
well as older patients with bronchiectasis
who are at higher risk for pulmonary
environmental mycobacterial infections.
This concept extends to pertinent
family members of patients with idiopathic
bronchiectasis who may warrant closer
monitoring if they also have dural sac
enlargement. We are also performing
whole-exome sequencing of a large cohort
of patients with idiopathic bronchiectasis
and will analyze them for an association
between an increased burden of genetic
variants in candidate genes associated with
the pathophysiology of heritable connective
tissue disorders and dural ectasia.
Conclusions
The addition of dural sac size as a
phenotypic marker of genetic variation in
heritable connective tissue disorder genes in
patients with idiopathic bronchiectasis adds
further specificity to the phenotypic
characterization of patients with idiopathic
bronchiectasis and nontuberculous
mycobacteria. Characterizing and grouping
patients with idiopathic bronchiectasis by
heritable connective tissue disorder features,
including dural sac size, improves the
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Figure 4. Comparison of L1–L5 (average) anterior–posterior dural sac diameter (AP-DSD) by feature. Analysis of idiopathic bronchiectasis group based on
nontuberculousMycobacterium (NTM) cultures (A), wrist sign (B), scoliosis (C ), and family history of bronchiectasis (BRX) (D). Of the 64 subjects with acid-
fast bacilli respiratory culture data, 24 had cultures with positive results for pathogenic species of NTM. Individuals with positive NTM cultures had a
significantly larger L1–L5 (average) AP-DSD than that of those with negative culture results (P = 0.007). Of the 62 subjects who were assessed for the wrist
sign, the 17 individuals with a positive wrist sign had a significantly larger L1–L5 (average) AP-DSD than that of those with a negative wrist sign (P = 0.003).
Of the 71 subjects with idiopathic bronchiectasis (IB) assessed for scoliosis, the 15 individuals with nonsevere scoliosis tended to have a larger L1–L5
(average) AP-DSD than that of those who did not have scoliosis (P = 0.130). Of the 66 IB families included in this analysis, the 14 individuals from families
with a history of IB tended to have a larger L1–L5 (average) AP-DSD than that of those who did not have a family history of IB (P = 0.149).
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possibility of detecting genetic variants
in these genes and pathways, leading to
an improved understanding of the
pathogenesis of bronchiectasis. Importantly,
the characterization of patients with
idiopathic bronchiectasis by dural sac
diameter also opens the possibility of
developing potential therapies designed to
slow or prevent the development of
bronchiectasis, such as angiotensin receptor
blockers and statins, which have been shown
to decrease aortic root dilation in patients
with Marfan syndrome (50). n
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